Safety and Efficacy of Proefferocytic Nanoparticles to Treat Atherosclerosis in a Porcine Model

• Sharika Bamezai,
• Tom Alsaigh,
• Mozhgan Lofti,
• Yapei Zhang,
• Gayatri S. Kumar,
• Fudi Wang,
• Jianqin Ye,
• Lingfeng Luo,
• Lars Maegdefessel,
• Yoko Kojima,
• Manisha Kumari,
• Caitlin Bell,
• Shaunak Adkar,
• Bryan R. Smith,
• Nick J. Leeper

Affiliations

Sharika Bamezai

Stanford University School of Medicine, Palo Alto, CA

Tom Alsaigh

UC San Diego School of Medicine, San Diego, CA

Mozhgan Lofti

Stanford University School of Medicine, Palo Alto, CA

Yapei Zhang

Michigan State University, East Lansing, MI

Gayatri S. Kumar

Stanford University School of Medicine, Palo Alto, CA

Fudi Wang

Stanford University School of Medicine, Palo Alto, CA

Jianqin Ye

Stanford, Vascular Surgery, Stanford, CA

Lingfeng Luo

Stanford University, Redwood City, CA

Lars Maegdefessel

Technical University Munich, Munich, Germany

Yoko Kojima

Stanford University, Stanford, CA

Manisha Kumari

Michigan State University, East Lansing, MI

Caitlin Bell

Stanford, Stanford, CA

Shaunak Adkar

Stanford, Stanford, CA, and Palo Alto, CA

Bryan R. Smith

Michigan State University, East Lansing, MI

Nick J. Leeper

Stanford University School of Medicine, Palo Alto, CA